Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Type

Guidance programme

Advice programme

Showing 1 to 73 of 73

TitleReference numberPublishedLast updated
Burosumab for treating X-linked hypophosphataemia in children and young peopleHST8
Dabrafenib with trametinib for treating BRAF V600E mutation-positive glioma in children and young people aged 1 year and overTA977
Epilepsies in children, young people and adultsQS211
Transition from children's to adults' servicesQS140
Guided self-help digital cognitive behavioural therapy for children and young people with mild to moderate symptoms of anxiety or low mood: early value assessmentHTE3
Minimally invasive fusionless posterior-approach surgery to correct idiopathic scoliosis in children and young peopleIPG765
Diabetes (type 1 and type 2) in children and young people: diagnosis and managementNG18
Somatrogon for treating growth disturbance in children and young people aged 3 years and overTA863
Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and educationNG213
Urinary tract infection in children and young peopleQS36
Vertebral body tethering for idiopathic scoliosis in children and young peopleIPG728
Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and overHST20
Epilepsies in children, young people and adultsNG217
Diabetes in children and young peopleQS125
Palforzia for treating peanut allergy in children and young peopleTA769
Looked-after children and young peopleNG205
Secukinumab for treating moderate to severe plaque psoriasis in children and young peopleTA734
Babies, children and young people's experience of healthcareNG204
Bronchiolitis in children: diagnosis and managementNG9
Intravenous fluid therapy in children and young people in hospitalNG29
Gastro-oesophageal reflux disease in children and young people: diagnosis and managementNG1
End of life care for infants, children and young people with life-limiting conditions: planning and managementNG61
Depression in children and young people: identification and managementNG134
Cochlear implants for children and adults with severe to profound deafnessTA566
Servo-n with Neurally Adjusted Ventilatory Assist (NAVA) for babies and childrenMIB163
Developmental follow-up of children and young people born pretermQS169
Next-generation sequencing panel for solid tumour cancers in childrenMIB133
Immunosuppressive therapy for kidney transplant in children and young peopleTA482
Cerebral palsy in children and young peopleQS162
Thora-3Di for assessing asthma in childrenMIB122
Faltering growth: recognition and management of faltering growth in childrenNG75
End of life care for infants, children and young peopleQS160
Developmental follow-up of children and young people born pretermNG72
Constipation in children and young people: diagnosis and managementCG99
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young peopleTA455
Antisocial behaviour and conduct disorders in children and young people: recognition and managementCG158
Mitochondrial disorders in children: Co-enzyme Q10ES11
Severe sialorrhoea (drooling) in children and young people with chronic neurological disorders: oral glycopyrronium bromideES5
Psychosis and schizophrenia in children and young people: recognition and managementCG155
Children's attachmentQS133
Intravenous fluid therapy in children and young people in hospitalQS131
Harmful sexual behaviour among children and young peopleNG55
Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional proceduresCG64
Bronchiolitis in childrenQS122
Transition from children's to adults' services for young people using health or social care servicesNG43
Gastro-oesophageal reflux in children and young peopleQS112
Children's attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into careNG26
Bipolar disorder, psychosis and schizophrenia in children and young peopleQS102
Obesity in children and young people: prevention and lifestyle weight management programmesQS94
Management of vomiting in children and young people with gastroenteritis: ondansetronESUOM34
Promoting tolerance of enteral feeds in children and young people: domperidoneESUOM18
Bedwetting in children and young peopleQS70
Constipation in children and young peopleQS62
Antisocial behaviour and conduct disorders in children and young peopleQS59
Cancer services for children and young peopleQS55
Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young peopleTA300
Weight management: lifestyle services for overweight or obese children and young peoplePH47
Depression in children and young peopleQS48
Looked-after children and young peopleQS31
Human growth hormone (somatropin) for the treatment of growth failure in childrenTA188
Physical activity for children and young peoplePH17
Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and overTA138
Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 yearsTA131
Serial transverse enteroplasty procedure (STEP) for bowel lengthening in parenteral nutrition-dependent childrenIPG232
Improving outcomes in children and young people with cancerCSG7
Balloon dilatation of systemic to pulmonary arterial shunts in childrenIPG77
Balloon valvuloplasty for aortic valve stenosis in adults and childrenIPG78
Balloon dilatation with or without stenting for pulmonary artery or non-valvar right ventricular outflow tract obstruction in childrenIPG76
Balloon angioplasty with or without stenting for coarctation or recoarctation of the aorta in adults and childrenIPG74
Vagus nerve stimulation for refractory epilepsy in childrenIPG50
Extracorporeal membrane oxygenation (ECMO) in postneonatal childrenIPG38
Inhaler devices for routine treatment of chronic asthma in older children (aged 5 to 15 years)TA38
Guidance on the use of inhaler systems (devices) in children under the age of 5 years with chronic asthmaTA10

Results per page

  1. 10
  2. 25
  3. 50
  4. All